(Q51260360)

2 April 2018

title

Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma. (English)

1 reference

2 April 2018

1 reference

Peng Hou

1

1 reference

2 April 2018

Meiju Ji

2

1 reference

2 April 2018

Bin Yang

3

1 reference

2 April 2018

Zaozao Chen

4

1 reference

2 April 2018

Junjun Qiu

5

1 reference

2 April 2018

Xin Shi

6

1 reference

2 April 2018

Zuhong Lu

7

1 reference

2 April 2018

language of work or name

English

0 references

publication date

1 April 2006

1 reference

2 April 2018

published in

Cancer

1 reference

2 April 2018

volume

106

1 reference

2 April 2018

issue

7

1 reference

2 April 2018

page(s)

1602-1609

1 reference

2 April 2018

Quantitative assessment of promoter hypermethylation during breast cancer development

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Stature of young people with malignant bone tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Surgical options for children with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Alteration of pRb/p16/cdk4 regulation in human osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Cytosine methylation and human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DNA methylation in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DNA methylation and breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DNA methylation: an alternative pathway to cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Novel agents for chemoprevention, screening methods, and sampling issues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Detection of p16 hypermethylation in gastric carcinomas using a seminested methylation-specific PCR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

MethyLight: a high-throughput assay to measure DNA methylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DNA methylation analysis by MethyLight technology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Methylation changes in faecal DNA: a marker for colorectal cancer screening?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

High sensitivity mapping of methylated cytosines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

DAP kinase links the control of apoptosis to metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21762

7 January 2021

Identifiers

DOI

10.1002/CNCR.21762

1 reference

2 April 2018

1 reference

2 April 2018